Recent progress of surface plasmon resonance in the development of coronavirus disease-2019 drug candidates
At the end of 2019, the new coronavirus caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) suddenly raged, bringing a severe public health crisis to the world. It is urgent to discover suitable drugs and treatment regimens against this coronavirus disease 2019 (COVID-19) and rela...
Guardado en:
Autores principales: | Qian Wang, Zhenming Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/818825880f674aab9df20cf773ac84dc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Post‐coronavirus disease 2019 organizing pneumonia confirmed pathologically by video‐assisted thoracoscopic surgery
por: Keishi Sugino, et al.
Publicado: (2021) -
Coronavirus disease 2019 gastrointestinal and liver manifestations in adults: A review
por: Apichet Sirinawasatien, et al.
Publicado: (2021) -
Clinical and Epidemiological Characteristics of 1283 Pediatric Patients with Coronavirus Disease 2019 during the First and Second Waves of the Pandemic—Results of the Pediatric Part of a Multicenter Polish Register SARSTer
por: Maria Pokorska-Śpiewak, et al.
Publicado: (2021) -
Paediatric Multisystem Inflammatory Syndrome Associated with COVID-19 Infection: A Case Series
por: Aneesha Mathew, et al.
Publicado: (2021) -
Immunopathogenesis of severe acute respiratory syndrome coronavirus-2: evolving knowledge and its current status
por: Nitin Saksena, et al.
Publicado: (2021)